Format

Send to

Choose Destination
Neurol Neuroimmunol Neuroinflamm. 2017 Feb 8;4(2):e325. doi: 10.1212/NXI.0000000000000325. eCollection 2017 Mar.

Maraviroc as possible treatment for PML-IRIS in natalizumab-treated patients with MS.

Author information

1
Institute of Neuroimmunology and Multiple Sclerosis (S.C.H., K.H.S., M.A.F., C.H.), Department of Neurology (S.C.H., K.H.S., C.H.), and Department of Diagnostic and Interventional Neuroradiology (B.H.), University Medical Center Hamburg-Eppendorf; and Neurological Private Practice (V.B., B.E.), Hamburg, Germany.

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center